🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 17 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/05/2002 | 7,29 | 7,46 | 7,25 | 7,33 | -0,41% | 2,81% | 1.706.400 |
| 23/05/2002 | 7,00 | 7,41 | 6,92 | 7,36 | +7,77% | 7,00% | 2.926.400 |
| 22/05/2002 | 6,64 | 6,94 | 6,56 | 6,83 | +2,40% | 5,80% | 133.200 |
| 21/05/2002 | 6,80 | 6,90 | 6,56 | 6,67 | -3,41% | 5,00% | 140.800 |
| 20/05/2002 | 7,00 | 7,10 | 6,75 | 6,90 | -1,43% | 4,93% | 248.600 |
| 17/05/2002 | 7,09 | 7,18 | 6,92 | 7,00 | -1,06% | 3,67% | 867.400 |
| 16/05/2002 | 6,91 | 7,23 | 6,88 | 7,08 | +2,46% | 5,07% | 155.200 |
| 15/05/2002 | 6,56 | 7,00 | 6,56 | 6,91 | +3,06% | 6,79% | 305.800 |
| 14/05/2002 | 6,45 | 6,73 | 6,45 | 6,70 | +3,47% | 4,34% | 243.600 |
| 13/05/2002 | 6,34 | 6,48 | 6,34 | 6,48 | +2,05% | 2,29% | 215.000 |
| 10/05/2002 | 6,45 | 6,45 | 6,25 | 6,35 | -0,47% | 3,10% | 239.000 |
| 09/05/2002 | 5,98 | 6,43 | 5,97 | 6,38 | +4,68% | 7,61% | 420.200 |
| 08/05/2002 | 5,80 | 6,16 | 5,73 | 6,09 | +5,45% | 7,41% | 176.800 |
| 07/05/2002 | 5,93 | 5,93 | 5,78 | 5,78 | -1,87% | 2,61% | 260.200 |
| 06/05/2002 | 5,93 | 5,99 | 5,86 | 5,89 | -1,51% | 2,19% | 45.400 |
| 03/05/2002 | 5,88 | 6,05 | 5,78 | 5,98 | +1,36% | 4,68% | 209.000 |
| 02/05/2002 | 6,00 | 6,04 | 5,71 | 5,90 | -2,48% | 5,50% | 126.600 |
| 01/05/2002 | 5,99 | 6,05 | 5,81 | 6,05 | +0,83% | 4,09% | 152.000 |
| 30/04/2002 | 5,96 | 6,03 | 5,81 | 6,00 | -0,08% | 3,69% | 528.600 |
| 29/04/2002 | 6,14 | 6,17 | 5,96 | 6,00 | -2,20% | 3,50% | 280.600 |
| 26/04/2002 | 6,25 | 6,33 | 6,12 | 6,14 | -2,00% | 3,36% | 399.000 |
| 25/04/2002 | 6,38 | 6,50 | 6,25 | 6,26 | -1,80% | 3,92% | 183.600 |
| 24/04/2002 | 6,42 | 6,43 | 6,34 | 6,38 | -0,93% | 1,33% | 69.200 |
| 23/04/2002 | 6,38 | 6,45 | 6,38 | 6,44 | -0,31% | 1,18% | 173.200 |
| 22/04/2002 | 6,50 | 6,50 | 6,33 | 6,46 | -0,31% | 2,69% | 148.000 |
| 19/04/2002 | 6,38 | 6,55 | 6,38 | 6,48 | +0,78% | 2,59% | 288.600 |
| 18/04/2002 | 6,57 | 6,67 | 6,37 | 6,43 | -3,24% | 4,49% | 511.200 |
| 17/04/2002 | 6,63 | 6,75 | 6,62 | 6,64 | -0,90% | 2,04% | 92.800 |
| 16/04/2002 | 6,63 | 6,75 | 6,58 | 6,70 | +1,13% | 2,64% | 326.000 |
| 15/04/2002 | 6,64 | 6,70 | 6,57 | 6,63 | +0,84% | 1,88% | 97.600 |